Loading…
Based on limited metadata, NeuroScience Solutions, Inc. received an FDA Warning Letter on April 10, 2019, regarding dietary supplement products. While the specific violations cannot be detailed without access to the full letter text, the warning indicates regulatory concerns within the dietary supplement category. The letter was issued through FDA channels, though the specific issuing office is not identified in the available metadata.